about
Plk1-mediated phosphorylation of Topors regulates p53 stabilityNotch activation drives adipocyte dedifferentiation and tumorigenic transformation in miceCREB-mediated transcriptional control.The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (Review).Different regions of hepatitis B virus X protein are required for enhancement of bZip-mediated transactivation versus transrepression.Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replicationPolo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidyCtBP2 downregulation during neural crest specification induces expression of Mitf and REST, resulting in melanocyte differentiation and sympathoadrenal lineage suppression.Technical standards for hepatitis B virus X protein (HBx) research.Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver CarcinogenesisEpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes.Three sequence-specific DNA-protein complexes are formed with the same promoter element essential for expression of the rat somatostatin geneDeregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis.Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity.RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis.Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression.Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives.Gene signatures in hepatocellular carcinoma (HCC).DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.Homeodomain transcription factor Phox2a, via cyclic AMP-mediated activation, induces p27Kip1 transcription, coordinating neural progenitor cell cycle exit and differentiation.The mitogenic function of hepatitis B virus X protein resides within amino acids 51 to 140 and is modulated by N- and C-terminal regulatory regions.Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytesTime-dependent activation of Phox2a by the cyclic AMP pathway modulates onset and duration of p27Kip1 transcription.Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy.The cAMP pathway regulates both transcription and activity of the paired homeobox transcription factor Phox2a required for development of neural crest-derived and central nervous system-derived catecholaminergic neurons.Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expressionAdenosine signaling promotes neuronal, catecholaminergic differentiation of primary neural crest cells and CNS-derived CAD cells.Differentiation-induced alterations in cyclic AMP signaling in the Cath.a differentiated (CAD) neuronal cell line.Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines.Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes.The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner.Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines.The hepatitis B virus X protein enhances the DNA binding potential and transcription efficacy of bZip transcription factors.Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis.Bacterial expression and characterization of the CREB bZip module: circular dichroism and 2D 1H-NMR studies.Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b~25.High-level activation of cyclic AMP signaling attenuates bone morphogenetic protein 2-induced sympathoadrenal lineage development and promotes melanogenesis in neural crest cultures.Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.Multiple regions of the porcine alpha-skeletal actin gene modulate muscle-specific expression in cell culture and directly injected skeletal muscle.
P50
Q24314588-03D1329A-EBD7-42A2-B6CF-B6BFB82F5D6EQ28389770-39BC63B9-5056-45E2-86CF-0AD126CFA4ECQ33592502-8E6F7B8E-2639-4DB3-925D-F939D4FF55ECQ33685206-6979766F-F1CA-4BDF-BA37-BDD9D6FBAA43Q33794363-04C47B8C-3008-4D9D-BF79-56E84FA11B51Q33867835-E57ECED6-E7ED-4546-8E33-8782BBB18D07Q34144573-A7D50251-A0DB-42E9-9078-5A53E4FA8DCEQ34742221-204DE7B3-EAF6-4C43-8C1D-07BEFA5050E4Q35060821-B01461A4-FF22-4972-B743-57A38DFA0025Q35609669-EF91B542-CDA8-4EA7-A2D1-1F8FC47CAE19Q35674884-C0A3060C-5E4C-48E5-89EB-1EFE8459EB70Q36033564-B6BF03EE-1372-41F2-8F00-30086FB1E384Q36788449-B8328FCA-4CC0-4BA5-BD24-BEF7C3B58BF5Q36993940-06CC92A0-0DAA-40BA-B9C3-C75C907B0AEFQ37074064-14A3A874-655C-4D99-8F31-93AE931D6367Q37276945-D816460D-254A-4902-A736-924B2796F2E1Q37457851-9DF6F6EE-C0E2-4F92-B43E-2A1D805E1377Q37581334-5E83D50C-0303-4794-B359-56B2A4790ECBQ37790070-5FF20F9E-A245-4114-887C-49F1C1A34F24Q38734999-FB792F6F-249A-406F-B6F5-9277D8E92346Q39127532-9A76CAEB-9EB3-4A7F-B715-07B459D766B0Q39291956-C218BDEB-0F6A-4EF9-9724-CC786D8D1F71Q39684768-8759B2A6-25C0-4B37-96F3-57E8DF3F5124Q39831318-516B6F09-ADEB-433B-AC19-F60C86BBBAE8Q39951895-68159883-E7B2-42D0-BD39-FD18F23F671CQ40365648-2DEF3BA6-F612-4136-B118-F58634994667Q40419557-C10EE59C-3BCD-4646-A35E-7DC6F8C21751Q40424274-A3D23011-1FC8-4F6C-8BC2-D67CCC1015A0Q40580663-1FA6C3B1-7F4E-41FA-AE3E-884232E9E2A5Q40760811-F4385F46-35ED-4278-B645-4249144AD932Q40791429-A633E70E-38D0-4138-8A17-4B05F7C2178BQ40796694-F84F443D-BD24-4C51-9FE5-068C6ED21D1CQ40980258-D9837380-ED69-4A50-A280-25E693C8989AQ41094269-A9126B90-E5E9-4ED4-9305-155390D7EF38Q41826006-ABB8A607-CDC0-46A7-940C-EF5BFE819FC2Q41947470-2A39D068-09E6-454A-94EB-D7AC0633AB70Q42040180-2F6FFC5D-040C-490D-AE7E-947406E6AE0FQ42181624-2A683691-810C-4593-9CA5-F5AD0E16A8C4Q42272234-A5F07657-3626-4FC1-B1D8-473C48BA11AAQ42460201-DF7B40E4-EF88-4488-A35D-F75CB640BB85
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ourania M Andrisani
@ast
Ourania M Andrisani
@en
Ourania M Andrisani
@es
Ourania M Andrisani
@nl
Ourania M Andrisani
@sl
type
label
Ourania M Andrisani
@ast
Ourania M Andrisani
@en
Ourania M Andrisani
@es
Ourania M Andrisani
@nl
Ourania M Andrisani
@sl
prefLabel
Ourania M Andrisani
@ast
Ourania M Andrisani
@en
Ourania M Andrisani
@es
Ourania M Andrisani
@nl
Ourania M Andrisani
@sl
P106
P21
P31
P496
0000-0002-6230-0303